BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20663282)

  • 41. An improved liquid chromatography-tandem mass spectrometry method for the quantification of 4-aminobiphenyl DNA adducts in urinary bladder cells and tissues.
    Randall KL; Argoti D; Paonessa JD; Ding Y; Oaks Z; Zhang Y; Vouros P
    J Chromatogr A; 2010 Jun; 1217(25):4135-43. PubMed ID: 19932483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
    Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decline of the hemoglobin adduct of 4-aminobiphenyl during withdrawal from smoking.
    Maclure M; Bryant MS; Skipper PL; Tannenbaum SR
    Cancer Res; 1990 Jan; 50(1):181-4. PubMed ID: 2293553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mass spectrometric analysis of tobacco-specific hemoglobin adducts.
    Schäffler G; Betz C; Richter E
    Environ Health Perspect; 1993 Mar; 99():187-9. PubMed ID: 8319620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haemoglobin adducts from aromatic amines and tobacco specific nitrosamines in pregnant smoking and non smoking women.
    Birgit Branner Cornelia Kutzer Wolfgang Wickenpflug Gerhard Scherer Wolf-Dieter Heller Elmar Richter
    Biomarkers; 1998; 3(1):35-47. PubMed ID: 23899255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative study of comprehensive gas chromatography-nitrogen chemiluminescence detection and gas chromatography-ion trap-tandem mass spectrometry for determining nicotine and carcinogen organic nitrogen compounds in thirdhand tobacco smoke.
    Ramírez N; Vallecillos L; Lewis AC; Borrull F; Marcé RM; Hamilton JF
    J Chromatogr A; 2015 Dec; 1426():191-200. PubMed ID: 26684592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
    Gan J; Skipper PL; Gago-Dominguez M; Arakawa K; Ross RK; Yu MC; Tannenbaum SR
    J Natl Cancer Inst; 2004 Oct; 96(19):1425-31. PubMed ID: 15467031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.
    Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM
    Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LC-MS/MS screening strategy for unknown adducts to N-terminal valine in hemoglobin applied to smokers and nonsmokers.
    Carlsson H; von Stedingk H; Nilsson U; Törnqvist M
    Chem Res Toxicol; 2014 Dec; 27(12):2062-70. PubMed ID: 25350717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haemoglobin adducts as biomarkers of exposure to tobacco-related nitrosamines.
    Myers SR; Ali MY
    Biomarkers; 2008 Mar; 13(2):145-59. PubMed ID: 18270868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of the trolox equivalent antioxidant capacity (TEAC) in plasma on the formation of 4-aminobiphenylhaemoglobin adducts in smokers.
    Dallinga JW; Haenen GR; Bast A; Van Schooten FJ
    Biomarkers; 2002; 7(4):291-8. PubMed ID: 12171756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke.
    Vineis P; Talaska G; Malaveille C; Bartsch H; Martone T; Sithisarankul P; Strickland P
    Int J Cancer; 1996 Jan; 65(3):314-6. PubMed ID: 8575850
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
    Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct.
    Talaska G; al-Juburi AZ; Kadlubar FF
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5350-4. PubMed ID: 2052611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
    Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
    Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GC/MS analysis of biologically important aromatic amines. Application to human dosimetry.
    Stillwell WG; Bryant MS; Wishnok JS
    Biomed Environ Mass Spectrom; 1987 May; 14(5):221-7. PubMed ID: 2955825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry.
    Lin D; Lay JO; Bryant MS; Malaveille C; Friesen M; Bartsch H; Lang NP; Kadlubar FF
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):11-6. PubMed ID: 7889831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of urinary aromatic amines in smokers and nonsmokers using a MIPs-SPE coupled with LC-MS/MS method.
    Yu J; Wang S; Zhao G; Wang B; Ding L; Zhang X; Xie J; Xie F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 May; 958():130-5. PubMed ID: 24735928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adducts of acrylonitrile with hemoglobin in nonsmokers and in participants in a smoking cessation program.
    Pérez HL; Segerbäck D; Osterman-Golkar S
    Chem Res Toxicol; 1999 Oct; 12(10):869-73. PubMed ID: 10525260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers.
    Bartsch H; Caporaso N; Coda M; Kadlubar F; Malaveille C; Skipper P; Talaska G; Tannenbaum SR; Vineis P
    J Natl Cancer Inst; 1990 Dec; 82(23):1826-31. PubMed ID: 2250298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.